Does TOLVAPTAN Cause Hepatic function abnormal? 245 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 245 reports of Hepatic function abnormal have been filed in association with TOLVAPTAN (Jynarque). This represents 2.7% of all adverse event reports for TOLVAPTAN.
245
Reports of Hepatic function abnormal with TOLVAPTAN
2.7%
of all TOLVAPTAN reports
26
Deaths
87
Hospitalizations
How Dangerous Is Hepatic function abnormal From TOLVAPTAN?
Of the 245 reports, 26 (10.6%) resulted in death, 87 (35.5%) required hospitalization, and 15 (6.1%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLVAPTAN. However, 245 reports have been filed with the FAERS database.
What Other Side Effects Does TOLVAPTAN Cause?
Death (800)
Thirst (624)
Off label use (560)
Renal impairment (534)
Underdose (448)
Product use in unapproved indication (446)
Wrong technique in product usage process (426)
Polyuria (390)
Product dose omission issue (379)
Inappropriate schedule of product administration (376)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which TOLVAPTAN Alternatives Have Lower Hepatic function abnormal Risk?
TOLVAPTAN vs TOPAMAX
TOLVAPTAN vs TOPIRAMATE
TOLVAPTAN vs TOPOTECAN
TOLVAPTAN vs TOPOTECAN\TOPOTECAN
TOLVAPTAN vs TOPROL